There were 1,852 press releases posted in the last 24 hours and 394,440 in the last 365 days.
For Immediate Release: January 13, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA released a fact sheet and constituent update to remind produce stakeholders of the …
For Immediate Release: January 10, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued the final guidance for the Foreign Supplier Verification Programs for Importers …
For Immediate Release: January 06, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA posted an update that the agency is closely monitoring the emergence of the XBB.1.5 …
For Immediate Release: January 06, 2023 Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of medications …
For Immediate Release: February 01, 2023 Today, the U.S. Food and Drug Administration approved Jesduvroq tablets (daprodustat) as the first oral treatment for anemia (decreased number of red blood cells) caused by chronic kidney disease for adults who have …
For Immediate Release: December 30, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced, through a Constituent Update and corresponding rule in the Federal Register, …
For Immediate Release: December 23, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA announced that the VQIP Application Portal would open on January 1, 2023 for …
For Immediate Release: December 22, 2022 Today, the U.S. Food and Drug Administration approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with human immunodeficiency virus type 1 (HIV-1), whose HIV infections …
For Immediate Release: December 20, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the agency published a piece for FDA Voices: “Office of Digital Transformation’s New Focus on …
FDA News Release Company prohibited from distributing drug products that violate the law For Immediate Release: December 19, 2022 Today, the U.S. District Court for the Western District of Oklahoma entered a consent decree against Qualgen LLC, an …
For Immediate Release: December 19, 2022 Statement From: Robert M. Califf, M.D., MACC Commissioner of Food and Drugs - Food and Drug Administration Earlier this year, I commissioned an external evaluation of the U.S. Food and Drug Administration’s Tobacco …
For Immediate Release: December 16, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA released a draft update to guidance for industry (GFI) #152, “Evaluating the Safety of …
For Immediate Release: December 16, 2022 Today, the U.S. Food and Drug Administration approved Adstiladrin (nadofaragene firadenovec-vncg), a non-replicating (cannot multiply in human cells) adenoviral vector based gene therapy indicated for the treatment …
For Immediate Release: December 16, 2022 Statement From: Peter Marks, M.D., PhD. Director - Center for Biologics Evaluation and Research (CBER) On Jan. 26, 2023, the U.S. Food and Drug Administration will hold a meeting of its Vaccines and Related …
For Immediate Release: December 13, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA updated the device shortage list to remove medical gloves (product codes LYY, LYZ, …
FDA News Release Rebyota Approved for the Prevention of Recurrence of Clostridioides difficile Infection in Adults For Immediate Release: November 30, 2022 Today, the U.S. Food and Drug Administration approved Rebyota, the first fecal microbiota product …
For Immediate Release: November 29, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued two guidance documents about food allergen labeling requirements to help the …
For Immediate Release: November 22, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued an emergency use authorization (EUA) for the Lucira COVID-19 and Flu Test for …
For Immediate Release: November 22, 2022 Today, the U.S. Food and Drug Administration approved Hemgenix (etranacogene dezaparvovec), an adeno-associated virus vector-based gene therapy for the treatment of adults with Hemophilia B (congenital Factor IX …
For Immediate Release: November 18, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Yesterday, the FDA provided an update on the Philips Respironics (Philips) June 2021 recall. …
